MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/meg.0000000000000517

Медицинская библиотека · European journal of gastroenterology & hepatology · 2016

Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.

Deterding Katja, Grüner Norbert, Buggisch Peter, Galle Peter R, Spengler Ulrich, Hinrichsen Holger, Berg Thomas, Potthoff Andrej, Grohennig Anika, Koch Armin, Diepolder Helmut, Lüth Stefan, Feyerabend Sandra, Jung Maria C, Rogalska-Taranta Magdalena, Schlaphoff Verena, Cornberg Markus, Manns Michael P, Wedemeyer Heiner, Wiegand Johannes, Hep-Net Acute HCV-III Study Group

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Neuropsychiatric symptoms of hepatitis C virus (HCV) infection and during peginterferon α therapy have been investigated in the chronic stage of the infection, but have not been described during the acute phase of the disease so far. We therefore evaluated anxiety and depression in patients with acute hepatitis C by the Hospital Anxiety and Depression Scale (HADS) within a clinical trial.

METHODS

Data were analysed from the German Hep-Net Acute HCV-III study. Anxiety and depression were characterized by an anxiety (HADS-A) and a depression subscale (HADS-D). More than eight points in each subscale were considered clinically relevant. Data were prospectively collected at baseline, end of treatment and at the end of the study.

RESULTS

At baseline, a HADS-A above eight points was observed significantly more frequently than a HADS-D above eight points [n=23/103 (22%) vs. n=12/103 (12%); P=0.041].A pathological HADS-A or HADS-D score did not correlate with age, sex, IL28B genotype, the probable mode of infection, HCV genotype or severity of disease as investigated by alanine aminotransferase and bilirubin levels.Antiviral therapy did not influence anxiety as 12/50 (24%) of patients had HADS-A above 8 at the end of therapy. The proportion of patients with HADS-D above eight points increased from 12% at baseline to 24% (n=12/50) at the end of therapy (P=0.06). HADS results were not associated with lost to follow-up or sustained virological response rates.

CONCLUSION

HADS data in acute HCV infection indicate that anxiety and depression do not correlate with severity of the disease, mode of acquisition, lost to follow-up and sustained virological response rates.

Для цитирования: Deterding Katja, Grüner Norbert, Buggisch Peter, Galle Peter R, Spengler Ulrich, Hinrichsen Holger, Berg Thomas, Potthoff Andrej, Grohennig Anika, Koch Armin, Diepolder Helmut, Lüth Stefan, Feyerabend Sandra, Jung Maria C, Rogalska-Taranta Magdalena, Schlaphoff Verena, Cornberg Markus, Manns Michael P, Wedemeyer Heiner, Wiegand Johannes, Hep-Net Acute HCV-III Study Group. Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.. European journal of gastroenterology & hepatology. 2016. DOI: 10.1097/meg.0000000000000517.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.